Overview

Gender

male

Investor Type

Investment Partner

Ryan brings to NVP more than twenty years of healthcare experience, a decade of which was as a growth equity and buyout investor. Combining deep medical knowledge and extensive strategic business experience, Ryan focuses on growth equity investments in the healthcare sector in NVP's Palo Alto office. Areas in which he invests include healthcare services, healthcare IT, medical devices, and specialty pharma. Ryan's most recent investment is Capsugel, the world leader in hard capsules and an innovator in drug-delivery systems.

Prior to joining NVP, Ryan was a Principal with The Carlyle Group and a Venture Partner with Industry Ventures, where he focused exclusively on healthcare service, pharmaceutical, and medical device investments from large cap buyouts to growth equity and venture.

At Carlyle, Ryan’s deals led to realized profitable exits of more than $1.8 billion equity value. He served as a member or observer on the Board of Directors of Align Technologies (NASDAQ: ALGN), AqueSys, Colin Medical, ConnectiCare, MedPointe Pharmaceuticals, Multiplan, NeoVista, Proteus Biomedical and Qualicaps.

At Industry Ventures, Ryan executed transactions involving Access Closure, Cardiofocus, Ingenuity, and Intarcia. Prior to joining Carlyle in 2002, Ryan was a consultant in the West Coast Healthcare Practice of McKinsey & Company, where he worked with a variety of biotechnology, pharmaceutical and medical device companies on corporate, R&D and marketing strategies.

Ryan has authored more than 25 peer-reviewed comparative effectiveness articles in publications such as JAMA, Lancet, Annals of Internal Medicine, and the Journal of Health Economics.

Ryan holds an M.D. from the University of California, San Francisco, School of Medicine. In addition, he earned an M.S. in health research and policy, and a B.A. in psychology from Stanford University. Ryan also attended Oxford University's Magdalen College.